Thebes Pharmaceuticals Private Limited, a active private limited company, was established on 03 April 2003 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231DL2003PTC119735. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.16 M.
It upholds a compliant status. Its leadership includes Anindita Mukherjee (Whole-Time Director), Hemant Kumar (Director), Rakesh Kumar Taneja (Director). Past directors included Supriyo Mukherjee, Nikhilananda Mukherjee. It holds ₹3.41 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-11 Third Floor, Pandav Nagar, New Delhi, Delhi, 110092.
U24231DL2003PTC119735
119735
03 April 2003
₹0.20 M
₹0.16 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Thebes Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anindita Mukherjee | Whole-Time Director | 25 Mar 2004 | Current |
| Hemant Kumar | Director | 21 Aug 2023 | Current |
| Rakesh Kumar Taneja | Director | 03 Apr 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Mar 2018 | Past |
| Pramod Abcsdd | Director | 25 Dec 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Thebes Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 12.6% decrease. The company also saw a substantial improvement in profitability, with a 981.83% increase in profit. The company's net worth Soared by an impressive increase of 34.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Thebes Pharmaceuticals had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,410,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2025 | Others | ₹3.41 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Thebes Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Thebes Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thebes Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 3.41 M with Charge ID 101154314 was registered on 04 Sep 2025. was recorded as a recent event.
Thebes Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Thebes Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Hemant Kumar was appointed as a Director was appointed as a Director on 21 Aug 2023 & has been associated with this company since 2 years 4 months . was completed.
Anindita Mukherjee was appointed as a Whole-time director was appointed as a Whole-time director on 25 Mar 2004 & has been associated with this company since 21 years 8 months . was recorded as a recent event.
Rakesh Kumar Taneja was appointed as a Director was appointed as a Director on 03 Apr 2003 & has been associated with this company since 22 years 8 months . was recorded as a recent event.
The CIN of Thebes Pharmaceuticals Private Limited is U24231DL2003PTC119735.
Thebes Pharmaceuticals Private Limited is headquartered at A-11 Third Floor, Pandav Nagar, New Delhi, Delhi, 110092.
Thebes Pharmaceuticals Private Limited was incorporated on 03 April 2003.
The current directors of Thebes Pharmaceuticals Private Limited are
The primary industry of Thebes Pharmaceuticals Private Limited is Trade.
Thebes Pharmaceuticals Private Limited is unlisted.
The authorized capital of Thebes Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.16 M.
The compliance status of Thebes Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX